Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.
Press releases published on April 15, 2025
Banzai Reports Fourth Quarter and Full Year 2024 Financial Results
GlobeNewswire
·
April 15, 2025
Revenue of $16.7 Million on a Consolidated, Pro-forma Basis for the Twelve Months Ending December 31, 2024, Representing 267% Annual Growth; Exceeded Guidance of $10 Million by 67% Q4 2024 Adjusted Net Loss Improved by $7.8 Million from ($9.2) Million in …
Jamf to Report First Quarter 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 15, 2025
MINNEAPOLIS, April 15, 2025 (GLOBE NEWSWIRE) -- Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, announced today it will report first quarter 2025 financial results for the period ended March 31, 2025, following the close of the …
可靈AI全系模型進入2.0時代 讓每個人都能用AI講出好故事
GlobeNewswire
·
April 15, 2025
香港, April 16, 2025 (GLOBE NEWSWIRE) -- 領先的內容社區及社交平台快手科技（「快手」或「公司」；港幣櫃台股份代號：01024 / 人民幣櫃台股份代號：81024）宣佈，可靈AI在北京舉行「靈感成真」2.0模型發佈會，宣佈基座模型再次升級，面向全球正式發佈可靈2.0視頻生成模型及可圖2.0圖像生成模型。 作為全球首個用戶可用的DiT視頻生成模型，可靈AI自去年6月上線至今的10個月時間裡，全球用戶規模已突破2,200萬。3月27日，全球知名AI基準測試機構 …
Kling AI Advances to the 2.0 Era, Empowering Everyone to Tell Great Stories with AI
GlobeNewswire
·
April 15, 2025
HONG KONG, April 15, 2025 (GLOBE NEWSWIRE) -- Kuaishou Technology (“Kuaishou” or the “Company”; HKD Counter Stock Code: 01024 / RMB Counter Stock Code: 81024), a leading content community and social platform, announced that Kling AI hosted the “From Vision …
Mercury Systems to Report Third Quarter Fiscal Year 2025 Financial Results on May 6, 2025
GlobeNewswire
·
April 15, 2025
ANDOVER, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a technology company that delivers mission-critical processing power to the edge, will release its third quarter fiscal year 2025 financial results after …
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
April 15, 2025
SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that on April 14, 2025, non- …
Diginex Limited and AIKYA Announce Strategic Alliance to Launch diginexESG in Malaysia, Advancing ESG Reporting and Sustainable Finance
GlobeNewswire
·
April 15, 2025
LONDON, April 15, 2025 (GLOBE NEWSWIRE) -- Diginex Limited (“Diginex”) (NASDAQ: DGNX), a leading impact technology company specializing in environmental, social, and governance (“ESG”) solutions, today announced a strategic alliance with AIKYA, a leading …
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
GlobeNewswire
·
April 15, 2025
LONDON, Ontario and BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company, today announced that the Company’s Cell Pouch Bio-hybrid Organ in clinical …
ARRAY Technologies, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
GlobeNewswire
·
April 15, 2025
ALBUQUERQUE, N.M., April 15, 2025 (GLOBE NEWSWIRE) -- ARRAY Technologies, Inc. (the “Company” or “ARRAY”) (Nasdaq: ARRY), a global leader in utility-scale solar tracking, today announced that the Company will release its first quarter 2025 results before …
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
GlobeNewswire
·
April 15, 2025
Merger creates a Nasdaq-listed, clinical-stage biopharmaceutical company – Tvardi Therapeutics – developing novel treatments targeting STAT3 to treat fibrosis-driven diseases Tvardi shares to begin trading under the symbol “TVRD” on April 16, 2025 Post- …
Rapid7 to Report First Quarter 2025 Financial Results on May 12
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- Rapid7, Inc. (NASDAQ: RPD), a leader in extended risk and threat detection, today announced that the company will release its first quarter 2025 financial results on Monday, May 12, 2025, after the financial …
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
GlobeNewswire
·
April 15, 2025
BOSTON, April 15, 2025 (GLOBE NEWSWIRE) -- NeuroNOS, a biopharmaceutical company focused on developing transformative treatments for Autism Spectrum Disorder (ASD) and Alzheimer’s disease (AD)conditions, and a subsidiary of Beyond Air (NASDAQ: XAIR), is …
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer
GlobeNewswire
·
April 15, 2025
- Initial results from randomized Phase 2 CRDF-004 trial in RAS-mut mCRC were released in December 2024 - - Additional clinical data from CRDF-004 trial expected in 1H 2025 - SAN DIEGO, April 15, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: …
Brilliant Earth to Report First Quarter 2025 Financial Results on May 6th
GlobeNewswire
·
April 15, 2025
SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that it will report first quarter 2025 …
Century Therapeutics to Host Live Fireside Chat Focused on Newly Prioritized Preclinical Cell Therapy Programs for Autoimmune Diseases and Cancer on Tuesday, April 22, 2025
GlobeNewswire
·
April 15, 2025
PHILADELPHIA, April 15, 2025 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in autoimmune disease and cancer, today …
Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for …
Inventiva annonce le dépôt de son Document d’Enregistrement Universel 2024 et de son Rapport Annuel 2024 (« Form 20-F »)
GlobeNewswire
·
April 15, 2025
Daix (France), New York City (New York, États-Unis), le 15 avril 2025 - Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
Xavier AI Launches the World’s First AI Strategy Consultant
GlobeNewswire
·
April 15, 2025
Wilmington, Delaware, April 15, 2025 (GLOBE NEWSWIRE) -- Xavier AI launches the first AI strategy consultant that provides clear, actionable business knowledge as presentation-ready slides. Designed for strategy, management, and marketing teams, the …
SIX MINING Achieves Unprecedented Surge in Global User Base Amid Bitcoin Market Volatility.
GlobeNewswire
·
April 15, 2025
Loughborough, UK, April 15, 2025 (GLOBE NEWSWIRE) -- In the latest record, SIX MINING has achieved an unprecedented surge in global user base amid Bitcoin market volatility. The platform provides global cryptocurrency investment enthusiasts with a cloud …
Best Legal Steroids For Muscle Growth, Cutting, Buying Anabolic Steroids, Testosterone As A Steroid, Steroids For Sale, How To Get Steroids, Metabolic Steroids (By CrazyBulk)
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Using Steroids for Bodybuilding Bodybuilding with steroids is usually divided into two parts: the bulking phase and the cutting phase. Bulking is for gaining muscle and strength, while cutting is for losing fat …